![Steven O’Day](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steven O’Day
Directeur Technique/Scientifique/R&D chez AGENUS INC.
Fortune : 213 682 $ au 31/05/2024
Profil
Steven O’Day currently works at Agenus, Inc., as Chief Medical Officer from 2021.
Dr. O’Day also formerly worked at John Wayne Cancer Institute, as Executive Director.
Dr. O’Day received his undergraduate degree from Williams College and doctorate degree from The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
AGENUS INC.
0,06% | 11/06/2024 | 13 619 ( 0,06% ) | 213 682 $ | 31/05/2024 |
Postes actifs de Steven O’Day
Sociétés | Poste | Début |
---|---|---|
AGENUS INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
Anciens postes connus de Steven O’Day
Sociétés | Poste | Fin |
---|---|---|
John Wayne Cancer Institute
![]() John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | Directeur/Membre du Conseil | - |
Formation de Steven O’Day
Williams College | Undergraduate Degree |
The Johns Hopkins University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
AGENUS INC. | Health Technology |
Entreprise privées | 1 |
---|---|
John Wayne Cancer Institute
![]() John Wayne Cancer Institute Miscellaneous Commercial ServicesCommercial Services John Wayne Cancer Institute is a medical institution that specializes in personalized cancer treatment. The private company is based in Santa Monica, CA. The company focuses on translating advanced cancer research into effective treatments for patients. | Commercial Services |